2121. Isavuconazole (ISAV) as Primary Anti-Fungal Prophylaxis (PAP) in Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS): An Open-Label, Prospective Study.

Item request has been placed!

Item request cannot be made.

Processing Request

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

المؤلفون: Bose, Prithviraj¹ (AUTHOR); McCue, David¹ (AUTHOR); Wurster, Sebastian¹ (AUTHOR); Wiederhold, Nathan P² (AUTHOR); Kadia, Tapan M¹ (AUTHOR); Borthakur, Gautam¹ (AUTHOR); Ravandi-Kashani, Farhad¹ (AUTHOR); Masarova, Lucia¹ (AUTHOR); Konopleva, Marina¹ (AUTHOR); Estrov, Zeev¹ (AUTHOR); Takahashi, Koichi¹ (AUTHOR); Yilmaz, Musa¹ (AUTHOR); Rausch, Caitlin R¹ (AUTHOR); Marx, Kayleigh¹ (AUTHOR); Qiao, Wei¹ (AUTHOR); Huang, Xuelin¹ (AUTHOR); Bivins, Carol A¹ (AUTHOR); Pierce, Sherry A¹ (AUTHOR); Kantarjian, Hagop M¹ (AUTHOR); Kontoyiannis, Dimitrios P¹ (AUTHOR)
المصدر:
Open Forum Infectious Diseases. 2019 Supplement, Vol. 6, pS718-S718. 1p.